 |
|
|
| |
Deep sequencing analysis of rilpivirine virologic failures in the Phase III studies ECHO and THRIVE shows no association with the presence of minority resistance associated variants at baseline (part II)
|
| |
| |
Reported by Jules Levin
Intl Resistance Workshop, Sitges Spain June 5-9 2012
V Van Eygen1, K Thys1, J Vingerhoets1, C Van Hove2, LT Rimsky1, J Aerssens1 and GR Picchio3
1Janssen Infectious Diseases, Beerse, Belgium; 2Janssen Pharmaceutica, Beerse, Belgium; 3Janssen R&D Inc, Titusville, NJ, USA
|
| |
|
|
|
|
|
